The Detection Performance of 18F-Prostate-Specific Membrane Antigen-1007 PET/CT in Primary Prostate Cancer A Systemic Review and Meta-analysis

被引:13
|
作者
Huang, Ya-Ting [1 ,2 ]
Tseng, Neng-Chuan [3 ,4 ]
Chen, Yen-Kung [5 ,6 ]
Huang, Kuo-How [7 ]
Lin, Hsiu-Ying [7 ,8 ]
Huang, Ya-Yao [1 ,9 ,10 ]
Hwang, Thomas I. S. [11 ,12 ,13 ]
Ou, Yen-Chuan [14 ,15 ]
机构
[1] Primo Biotechnol Co Ltd, Taipei, Taiwan
[2] Camillian St Marys Hosp Luodong, Dept Med Educ & Res, Yilan, Taiwan
[3] Tungs Taichung Metro Harbor Hosp, Div Nucl Med, Taichung, Taiwan
[4] China Med Univ, Dept Publ Hlth, Taichung, Taiwan
[5] Shin Kong Wu Ho Su Mem Hosp, Nucl Med & PET Ctr, Taipei, Taiwan
[6] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan
[7] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan
[8] Natl Taiwan Univ Hosp, Dept Nursing, Taipei, Taiwan
[9] Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan
[10] Natl Taiwan Univ, Mol Imaging Ctr, Taipei, Taiwan
[11] Shin Kong Wu Ho Su Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan
[12] Fu Jen Catholic Univ, Sch Med, Div Urol, New Taipei, Taiwan
[13] Taipei Med Univ, Dept Urol, Taipei, Taiwan
[14] Tungs Taichung Metro Harbor Hosp, Dept Surg, Div Urol, Taichung, Taiwan
[15] Tungs Taichung Metro Harbor Hosp, Dept Res, Taichung, Taiwan
关键词
F-18-PSMA-1007; PET; CT; prostate-specific membrane antigen; prostate cancer; PSMA; BIOPSY; BIODISTRIBUTION; RADIOTRACERS; RISK; F-18; MRI; MEN; PSA;
D O I
10.1097/RLU.0000000000004228
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Multiple tools are now available to determine the requirement for a biopsy to diagnose prostate cancer, and PET/CT with radiolabeled prostate-specific membrane antigen (PSMA)-targeting radiotracers has been recommended for detecting primary prostate cancer. Particularly, the radiotracer F-18-PSMA-1007 was found to be more favorable for primary tumors compared with other PSMA-targeting radiotracers because of its low clearance via the urinary tract and better image resolution. Thus, we performed a systematic review and meta-analysis to more accurately evaluate the detection performance of F-18-PSMA-1007 PET/CT in primary prostate cancer patients. Methods An update on the databases of PubMed/MEDLINE, EMBASE, and Cochrane Library for comprehensive literature search was performed on September 30, 2021. The pooling detection rate was calculated on a per-patient basis. The pooling median of the SUVmax was analyzed from the included studies. Furthermore, the positive predictive value of F-18-PSMA-1007 PET/CT with pathologic lesions was analyzed using the criterion standard. Results Twelve studies (540 patients total) were included in the meta-analysis. The overall pooling detection rate of F-18-PSMA-1007 per patient was 94%, and the pooling median of SUVmax located at the intraprostate tumor was 16 (range, 3.7-77.7). The positive predictive value of F-18-PSMA-1007 per lesion with histopathological validation was 0.90, detecting regional lymph node metastasis was 0.94, and detecting localized prostatic tumors was 0.84. Conclusions In the current meta-analysis, we revealed the excellent performance of F-18-PSMA-1007 to detect localized prostatic tumor lesions and regional lymph node metastasis. Moreover, the uptake of localized tumors in primary prostate cancer was nearly liver uptake and may be considered a suspicious malignancy if it was equal to or greater than the liver uptake.
引用
收藏
页码:755 / 762
页数:8
相关论文
共 50 条
  • [1] Duodenal Adenocarcinoma Mimicking Metastasis of Prostate Cancer on 18F-Prostate-Specific Membrane Antigen-1007 PET/CT
    Soeda, Fumihiko
    Watabe, Tadashi
    Kato, Hiroki
    Uemura, Motohide
    Nonomura, Norio
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (01) : 49 - 51
  • [2] Multimodal radiomics based on 18F-Prostate-specific membrane antigen-1007 PET/CT and multiparametric MRI for prostate cancer extracapsular extension prediction
    Pan, Kehua
    Yao, Fei
    Hong, Weifeng
    Xiao, Juan
    Bian, Shuying
    Zhu, Dongqin
    Yuan, Yaping
    Zhang, Yayun
    Zhuang, Yuandi
    Yang, Yunjun
    BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1154): : 408 - 414
  • [3] Pituitary Metastasis of Renal Cell Carcinoma Characterized by 18F-Prostate-Specific Membrane Antigen-1007 PET/CT
    Tariq, Arsalan
    Raman, Vignesh
    Alexander, Hamish
    Roberts, Matthew J.
    Thomas, Paul
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (04) : E346 - E347
  • [4] Head-to-Head Comparison of 18F-Prostate-Specific Membrane Antigen-1007 and 18F-Fluorocholine PET/CT in Biochemically Relapsed Prostate Cancer
    Witkowska-Patena, Ewa
    Gizewska, Agnieszka
    Dziuk, Miroslaw
    Misko, Jolanta
    Budzynska, Anna
    Walecka-Mazur, Agata
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (12) : E629 - E633
  • [5] 18F-Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate Cancer
    Witkowska-Patena, Ewa
    Gizewska, Agnieszka
    Misko, Jolanta
    Dziuk, Miroslaw
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E401 - E403
  • [6] False-Positive 18F-Prostate-Specific Membrane Antigen-1007 PET/CT Caused by Hepatic Multifocal Inflammatory Foci
    Ladron-de-Guevara, David
    Canelo, Alejando
    Piottante, Antonio
    Regonesi, Carlos
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (02) : E80 - E83
  • [7] Renal Infarction Imaged With [18F]Prostate-Specific Membrane Antigen-1007 PET/CT
    Ahmadi Bidakhvidi, Niloefar
    Van Craenenbroeck, Amaryllis H.
    Oyen, Raymond
    Van Laere, Koen
    Goffin, Karolien
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (02) : 172 - 173
  • [8] Detection rate of fluorine-18 prostate-specific membrane antigen-1007 PET/CT for prostate cancer in primary staging and biochemical recurrence with different serum PSA levels: A systematic review and meta-analysis
    Liu, Xue
    Jiang, Tao
    Gao, CaiLiang
    Liu, HuiTing
    Sun, Yu
    Zou, Qiao
    Tang, Rui
    Zeng, WenBing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Incidental detection of primary hepatocellular carcinoma on 18F-prostate-specific membrane antigen-1007 positron emission tomography/computed tomography imaging in a patient with prostate cancer A case report
    Zhao, Hongguang
    Li, Yinghua
    Hou, Sen
    Dai, Yuyin
    Lin, Chenghe
    Xu, Songbai
    MEDICINE, 2020, 99 (41) : E22486
  • [10] Fluorine-18 Prostate-Specific Membrane Antigen-1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer
    Mookerji, Nikhile
    Pfanner, Tyler
    Hui, Amaris
    Huang, Guocheng
    Albers, Patrick
    Mittal, Rohan
    Broomfield, Stacey
    Dean, Lucas
    St. Martin, Blair
    Jacobsen, Niels-Erik
    Evans, Howard
    Gao, Yuan
    Hung, Ryan
    Abele, Jonathan
    Dromparis, Peter
    Lima, Joema Felipe
    Bismar, Tarek
    Michelakis, Evangelos
    Sutendra, Gopinath
    Wuest, Frank
    Tu, Wendy
    Adam, Benjamin A.
    Fung, Christopher
    Tamm, Alexander
    Kinnaird, Adam
    JAMA ONCOLOGY, 2024, 10 (08) : 1097 - 1103